Zhiguo Hou

Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer

Zhenyu Lin, Ming Cai, Peng Zhang et al. · Journal for ImmunoTherapy of Cancer · 2021 · 164 citations · Full text

Medicine, Oncology, Surgery +17

Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine–Refractory Differentiated Thyroid Cancer

Yansong Lin, Shukui Qin, Zhiyong Li et al. · JAMA Oncology · 2021 · 93 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Camrelizumab plus apatinib as second-line treatment for advanced oesophageal squamous cell carcinoma (CAP 02): a single-arm, open-label, phase 2 trial

Xiangrui Meng, Tao Wu, Yonggui Hong et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 86 citations

Medicine, Oncology, Pharmacology +11

Effect of Apatinib Plus Pegylated Liposomal Doxorubicin vs Pegylated Liposomal Doxorubicin Alone on Platinum-Resistant Recurrent Ovarian Cancer

Tiantian Wang, Jie Tang, Hongying Yang et al. · JAMA Oncology · 2022 · 86 citations · Full text

Medicine, Oncology, Pharmacology +17

The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction

Zhaoqing Tang, Yan Wang, Dan Liu et al. · Nature Communications · 2022 · 84 citations · Full text

Medicine, Oncology, Pharmacotherapy +17